NO20052362L - Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner - Google Patents
Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjonerInfo
- Publication number
- NO20052362L NO20052362L NO20052362A NO20052362A NO20052362L NO 20052362 L NO20052362 L NO 20052362L NO 20052362 A NO20052362 A NO 20052362A NO 20052362 A NO20052362 A NO 20052362A NO 20052362 L NO20052362 L NO 20052362L
- Authority
- NO
- Norway
- Prior art keywords
- dalbavancin
- methods
- treatment
- bacterial infections
- administering
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US42765402P | 2002-11-18 | 2002-11-18 | |
US48569403P | 2003-07-08 | 2003-07-08 | |
US49504803P | 2003-08-13 | 2003-08-13 | |
US49648303P | 2003-08-19 | 2003-08-19 | |
PCT/US2003/036127 WO2004045636A1 (en) | 2002-11-18 | 2003-11-14 | Methods of administering dalbavancin for treatment of bacterial infections |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20052362D0 NO20052362D0 (no) | 2005-05-12 |
NO20052362L true NO20052362L (no) | 2005-08-17 |
Family
ID=32330046
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20052362A NO20052362L (no) | 2002-11-18 | 2005-05-12 | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner |
Country Status (15)
Country | Link |
---|---|
US (12) | US6900175B2 (ko) |
EP (1) | EP1565201B1 (ko) |
JP (3) | JP5519090B2 (ko) |
KR (2) | KR20120056310A (ko) |
AU (3) | AU2003294262B2 (ko) |
CA (1) | CA2506236C (ko) |
DK (1) | DK1565201T3 (ko) |
ES (1) | ES2712656T3 (ko) |
HK (2) | HK1083684A1 (ko) |
HU (1) | HUE041133T2 (ko) |
IL (3) | IL168327A (ko) |
MX (1) | MXPA05005338A (ko) |
NO (1) | NO20052362L (ko) |
PT (1) | PT1565201T (ko) |
WO (3) | WO2004045637A1 (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO345529B1 (no) * | 2004-04-27 | 2021-03-29 | Vicuron Pharm Inc | Dalbavancin-materialer for behandling av bakterielle infeksjoner |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060074014A1 (en) * | 2002-11-18 | 2006-04-06 | Vicuron Pharmaceuticals Inc. | Dalbavancin compositions for treatment of bacterial infections |
AU2003294262B2 (en) * | 2002-11-18 | 2007-08-23 | Vicuron Pharmaceuticals Inc. | Methods of administering dalbavancin for treatment of bacterial infections |
US20090062182A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched dalbavancin |
US8389583B2 (en) * | 2008-05-23 | 2013-03-05 | Zurex Pharma, Inc. | Antimicrobial compositions and methods of use |
US20110132607A1 (en) * | 2009-12-07 | 2011-06-09 | Schlumberger Technology Corporation | Apparatus and Technique to Communicate With a Tubing-Conveyed Perforating Gun |
JP6540705B2 (ja) | 2013-12-19 | 2019-07-10 | ジーイー・ヘルスケア・バイオサイエンス・アクチボラグ | 生物学的液体処理システムのための遠隔操作弁 |
MX2017000676A (es) | 2014-07-17 | 2018-01-11 | The Medicines Co | Oritavancina de alta pureza y metodo para producir la misma. |
SG11201703568WA (en) | 2014-11-06 | 2017-05-30 | Xellia Pharmaceuticals Aps | Glycopeptide compositions |
KR102091852B1 (ko) * | 2015-03-02 | 2020-03-23 | 코로나리콘셉츠 엘엘씨 | Peg 대사산물 및 peg 분해 생성물 검정을 위한 화합물 및 방법 |
JP6983660B2 (ja) | 2015-05-08 | 2021-12-17 | スペクトラル プラットフォームス インコーポレイテッド | アルブミンに基づく非共有結合性複合体およびその使用方法 |
WO2017179003A1 (en) | 2016-04-15 | 2017-10-19 | Lupin Limited | Topical compositions for ophthalmic and otic use |
US11105747B2 (en) | 2017-03-20 | 2021-08-31 | Spectral Platforms, Inc. | Spectroscopic methods to detect and characterize microorganisms |
KR20200045468A (ko) * | 2017-07-10 | 2020-05-04 | 콘트라펙트 코포레이션 | 용균 단백질 항균 활성의 혈액 성분 강화 및 이의 방법 및 용도 |
CN110183519B (zh) * | 2019-05-06 | 2023-04-11 | 大邦(湖南)生物制药有限公司 | 一种达巴万星关键中间体a40926的分离纯化方法 |
CN112480214B (zh) * | 2020-12-14 | 2023-03-28 | 成都雅途生物技术有限公司 | 一种达巴万星关键中间体a40926的制备方法 |
EP4014965A1 (en) | 2020-12-16 | 2022-06-22 | EVER Valinject GmbH | Aqueous solution |
CN116710470A (zh) | 2021-01-11 | 2023-09-05 | 埃克斯利亚制药有限公司 | 合成方法 |
CN115215926A (zh) * | 2022-08-12 | 2022-10-21 | 丽珠集团福州福兴医药有限公司 | 达巴万星母核及其纯化方法、达巴万星及其合成方法 |
WO2024079223A1 (en) * | 2022-10-12 | 2024-04-18 | Xellia Pharmaceuticals Aps | Liquid dalbavancin composition |
WO2024079224A1 (en) * | 2022-10-12 | 2024-04-18 | Xellia Pharmaceuticals Aps | Liquid dalbavancin composition |
Family Cites Families (56)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US573679A (en) * | 1896-12-22 | Apparatus for mowing hay | ||
US541616A (en) * | 1895-06-25 | Elevator attachment | ||
GB1496386A (en) * | 1975-03-05 | 1977-12-30 | Lepetit Spa | Antibiotics |
US4195079A (en) * | 1979-01-31 | 1980-03-25 | Pfizer Inc. | New polycyclic ether antibiotic |
CA1183789A (en) | 1981-08-04 | 1985-03-12 | Kiyoshi Isono | Antibiotic 76-11, process for the production thereof, anticoccidiosis agent and domestic animals growth accelerator comprising the same as an effective ingredient |
US4578271A (en) | 1982-05-24 | 1986-03-25 | Fujisawa Pharmaceutical Co., Ltd. | Biologically active WS 6049 substances, a process for the production thereof and their pharmaceutical compositions |
FI73697C (fi) | 1982-06-08 | 1987-11-09 | Lepetit Spa | Foerfarande foer framstaellning av individuella faktorer 1, 2, 3, 4 och 5 av teikomysin a2. |
FR2548021B1 (fr) | 1983-06-29 | 1986-02-28 | Dick P R | Compositions pharmaceutiques dermiques a action prolongee et continue a base d'acides gras essentiels |
GB8415092D0 (en) * | 1984-06-13 | 1984-07-18 | Lepetit Spa | Ester derivatives |
GB8425685D0 (en) * | 1984-10-11 | 1984-11-14 | Lepetit Spa | Antibiotic a 40926 complex |
GB8428619D0 (en) * | 1984-11-13 | 1984-12-19 | Lepetit Spa | Derivatives of antibiotic l 17046 |
US4914187A (en) * | 1984-11-13 | 1990-04-03 | Gruppo Lepetit S.P.A | Ester derivatives of antibiotic L 17046 |
GB8512795D0 (en) | 1985-05-21 | 1985-06-26 | Lepetit Spa | Increasing ratio of components of teicoplanin a2 complex |
GB8531846D0 (en) * | 1985-12-30 | 1986-02-05 | Lepetit Spa | Antibiotic a 40926 mannosyl aglycon |
GB8608809D0 (en) | 1986-04-11 | 1986-05-14 | Lepetit Spa | Antibiotic |
GB8621911D0 (en) * | 1986-09-11 | 1986-10-15 | Lepetit Spa | Increasing ratio of components of anti-biotic complex |
GB8621912D0 (en) * | 1986-09-11 | 1986-10-15 | Lepetit Spa | Increasing ratio of components of anti-biotic complex |
GR871488B (en) | 1986-10-10 | 1987-11-12 | Lepetit Spa | New antibiotics |
GB8715735D0 (en) * | 1987-07-03 | 1987-08-12 | Lepetit Spa | De-mannosyl teicoplanin derivatives |
US4882313A (en) * | 1987-07-31 | 1989-11-21 | Smithkline Beckman Corporation | Carboxamide derivatives of glycopeptides |
GB8726859D0 (en) | 1987-11-17 | 1987-12-23 | Lepetit Spa | 22-dechlorotei-coplanins |
US5004605A (en) * | 1987-12-10 | 1991-04-02 | Cetus Corporation | Low pH pharmaceutical compositions of recombinant β-interferon |
FR2628269B1 (fr) * | 1988-03-04 | 1990-07-27 | Sgs Thomson Microelectronics | Dispositif de demarrage progressif d'une alimentation a decoupage |
ATE134646T1 (de) | 1988-12-27 | 1996-03-15 | Lepetit Spa | C63-amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplanine |
IE64155B1 (en) | 1989-03-29 | 1995-07-12 | Lepetit Spa | New substituted alkylamide derivatives of teicoplanin |
JPH03193735A (ja) * | 1989-12-22 | 1991-08-23 | Shionogi & Co Ltd | グリコペプチド系抗生物質の安定化組成物 |
US5030619A (en) * | 1990-04-16 | 1991-07-09 | Miles Inc. | Synergistic fungicidal composition |
US5606036A (en) * | 1991-03-27 | 1997-02-25 | Gruppo Lepetit Spa | Antibiotic A 40926 ester derivatives |
JP2783722B2 (ja) * | 1991-07-12 | 1998-08-06 | 麒麟麦酒株式会社 | スピカマイシン誘導体およびそれを含む抗腫瘍剤 |
ATE125551T1 (de) | 1991-07-29 | 1995-08-15 | Lepetit Spa | Amidderivate vom antibiotikum a 40926. |
US5750509A (en) * | 1991-07-29 | 1998-05-12 | Gruppo Lepetit S.P.A. | Amide derivatives of antibiotic A 40926 |
US6384013B1 (en) * | 1992-03-19 | 2002-05-07 | Eli Lilly And Company | Cyclic peptide antifungal agents and process for preparation thereof |
US5882900A (en) * | 1992-09-10 | 1999-03-16 | Gruppo Lepetit S.P.A. | Process for the selective increase of production of antibiotic GE 2270 factor a by adding vitamin B12 to nutrient medium |
CA2112776C (en) * | 1993-01-21 | 2002-11-12 | Masakazu Tsuchiya | Process for inhibiting activity of endotoxin |
WO1994025588A2 (en) * | 1993-04-30 | 1994-11-10 | Biognostik Gesellschaft für Biomolekulare Diagnostik mbH | ANTISENSE-OLIGONUCLEOTIDES FOR THE TREATMENT OF IMMUNOSUPPRESSIVE EFFECTS OF TRANSFORMING GROWTH FACTOR-β (TGF-β) |
SI9500039B (sl) * | 1995-02-07 | 2002-02-28 | Lek, | Nov kombiniran postopek čiščenja Vankomicin hidroklorida |
DK0801655T3 (da) * | 1995-02-07 | 1999-02-08 | Biosearch Italia Spa | Basiske prolinamidderivater af GE 2270 og GE 2270-lignende antibiotika |
DK0808326T3 (da) * | 1995-02-07 | 2001-10-01 | Biosearch Italia Spa | Basiske oxazolinamidderivater af GE2270 og GE2270-lignende antibiotika |
US5789308A (en) * | 1995-06-06 | 1998-08-04 | Advanced Micro Devices, Inc. | Manufacturing method for wafer slice starting material to optimize extrinsic gettering during semiconductor fabrication |
CA2180206A1 (en) * | 1995-06-30 | 1996-12-31 | Motoya Ohshika | Freeze-dried preparation for pharmaceutical use |
ES2224173T3 (es) * | 1995-07-05 | 2005-03-01 | Aventis Bulk S.P.A. | Purificacion de antibioticos dalbaheptidos por enfoque isoelectrico. |
DE19600590A1 (de) * | 1996-01-10 | 1997-07-24 | Tzn Forschung & Entwicklung | Schutzvorrichtung für optische Systeme zur Vermeidung von Schäden bei Bestrahlung dieser Systeme mit Laserlicht |
JP2000505438A (ja) * | 1996-02-14 | 2000-05-09 | バイオサーチ・イタリア・ソチエタ・ペル・アチオニ | 抗生物質GE2270因子C▲下2a▼、D▲下2▼およびEの誘導体 |
AU2441697A (en) | 1996-04-12 | 1997-11-07 | Eli Lilly And Company | Covalently-linked glycopeptide dimers |
JP2000508671A (ja) * | 1996-04-23 | 2000-07-11 | バイオサーチ・イタリア・ソチエタ・ペル・アチオニ | 抗生物質a40926のアミド誘導体の改善された化学的製造法 |
US5935238A (en) * | 1997-06-19 | 1999-08-10 | Sun Microsystems, Inc. | Selection from multiple fetch addresses generated concurrently including predicted and actual target by control-flow instructions in current and previous instruction bundles |
JP4204655B2 (ja) * | 1997-08-08 | 2009-01-07 | 株式会社ルネサステクノロジ | パルス出力機能付マイクロコンピュータ |
CA2255140A1 (en) | 1997-12-23 | 1999-06-23 | Eli Lilly And Company | Echinocandin binding domain of 1,3-.beta.-glucan synthase |
US6541616B1 (en) * | 1998-10-01 | 2003-04-01 | Antex Biologics Inc. | Moraxella catarrhalis protein, gene sequence and uses thereof |
US6417180B1 (en) | 1998-10-07 | 2002-07-09 | University Of Massachusetts | Zinc finger-reactive antimicrobial compounds |
AU768204B2 (en) * | 1998-12-23 | 2003-12-04 | Cumberland Pharmaceuticals Inc. | Glycopeptide derivatives and pharmaceutical compositions containing the same |
TWI233805B (en) * | 1999-07-01 | 2005-06-11 | Fujisawa Pharmaceutical Co | Stabilized pharmaceutical composition in lyophilized form as antifungal agent |
WO2001083520A2 (en) | 2000-05-02 | 2001-11-08 | Theravance,Inc | Polyacid glycopeptide derivatives |
WO2003070756A2 (de) | 2002-02-18 | 2003-08-28 | Combinature Biopharm Ag | Neue glycopeptid-antibiotika und verfahren zu deren synthetisierung |
US7119061B2 (en) * | 2002-11-18 | 2006-10-10 | Vicuron Pharmaceuticals, Inc. | Dalbavancin compositions for treatment of bacterial infections |
AU2003294262B2 (en) * | 2002-11-18 | 2007-08-23 | Vicuron Pharmaceuticals Inc. | Methods of administering dalbavancin for treatment of bacterial infections |
-
2003
- 2003-11-14 AU AU2003294262A patent/AU2003294262B2/en not_active Expired
- 2003-11-14 CA CA2506236A patent/CA2506236C/en not_active Expired - Lifetime
- 2003-11-14 MX MXPA05005338A patent/MXPA05005338A/es active IP Right Grant
- 2003-11-14 HU HUE03789744A patent/HUE041133T2/hu unknown
- 2003-11-14 US US10/714,261 patent/US6900175B2/en active Active
- 2003-11-14 KR KR1020127012832A patent/KR20120056310A/ko not_active Application Discontinuation
- 2003-11-14 DK DK03789744.4T patent/DK1565201T3/en active
- 2003-11-14 US US10/493,558 patent/US20050090433A1/en not_active Abandoned
- 2003-11-14 ES ES03789744T patent/ES2712656T3/es not_active Expired - Lifetime
- 2003-11-14 EP EP03789744.4A patent/EP1565201B1/en not_active Expired - Lifetime
- 2003-11-14 WO PCT/US2003/036779 patent/WO2004045637A1/en not_active Application Discontinuation
- 2003-11-14 US US10/714,166 patent/US20050130909A1/en not_active Abandoned
- 2003-11-14 JP JP2004570384A patent/JP5519090B2/ja not_active Expired - Lifetime
- 2003-11-14 AU AU2003298662A patent/AU2003298662A1/en not_active Abandoned
- 2003-11-14 PT PT03789744T patent/PT1565201T/pt unknown
- 2003-11-14 WO PCT/US2003/036399 patent/WO2004046196A2/en not_active Application Discontinuation
- 2003-11-14 US US10/713,924 patent/US20050004011A1/en not_active Abandoned
- 2003-11-14 AU AU2003299561A patent/AU2003299561A1/en not_active Abandoned
- 2003-11-14 WO PCT/US2003/036127 patent/WO2004045636A1/en active Application Filing
- 2003-11-14 KR KR1020057008951A patent/KR101173310B1/ko active IP Right Grant
-
2004
- 2004-04-16 US US10/828,439 patent/US7115564B2/en not_active Expired - Lifetime
- 2004-04-16 US US10/828,379 patent/US20040220122A1/en not_active Abandoned
- 2004-04-16 US US10/828,483 patent/US20040198715A1/en not_active Abandoned
- 2004-04-20 US US10/829,068 patent/US20040224908A1/en not_active Abandoned
- 2004-09-15 US US10/942,604 patent/US20050130914A1/en not_active Abandoned
- 2004-09-15 US US10/942,197 patent/US20050032721A1/en not_active Abandoned
-
2005
- 2005-05-02 IL IL168327A patent/IL168327A/en active IP Right Grant
- 2005-05-12 NO NO20052362A patent/NO20052362L/no not_active Application Discontinuation
-
2006
- 2006-05-23 HK HK06105915A patent/HK1083684A1/xx not_active IP Right Cessation
-
2008
- 2008-08-19 HK HK08109254.4A patent/HK1114014A1/xx not_active IP Right Cessation
-
2009
- 2009-05-28 US US12/473,390 patent/US20090298748A1/en not_active Abandoned
- 2009-05-29 US US12/474,438 patent/US20090305953A1/en not_active Abandoned
-
2011
- 2011-04-05 JP JP2011083790A patent/JP2011157381A/ja active Pending
-
2013
- 2013-04-16 JP JP2013085785A patent/JP2013155188A/ja active Pending
-
2014
- 2014-02-06 IL IL230875A patent/IL230875A0/en unknown
-
2015
- 2015-07-13 IL IL239913A patent/IL239913B/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NO345529B1 (no) * | 2004-04-27 | 2021-03-29 | Vicuron Pharm Inc | Dalbavancin-materialer for behandling av bakterielle infeksjoner |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20052362L (no) | Fremgangsmater for administrering av dalbavancin for behandling av bakterielle infeksjoner | |
NO20064287L (no) | Dalbavancin-materialer for behandling av bakterielle infeksjoner | |
CY1116464T1 (el) | Θεραπεια συνδυασμου για τη θεραπευτικη αγωγη διαταραχων ανεπαρκειας πρωτεϊνης | |
MXPA05006670A (es) | Administracion de capsaicinoides. | |
HK1073608A1 (en) | Treatment of alpha-galactosidase a deficiency | |
WO1999008691A3 (en) | Use of locally delivered metal ions for treatment of periodontal disease | |
WO2002078627A3 (en) | N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity | |
NO20090887L (no) | Fremgangsmate for behandling og forebygging av mukositt | |
MX2009003532A (es) | Tratamiento de hiperbilirrubinemia infantil utilizando bajas dosis de estansoporfina. | |
SG162614A1 (en) | Bicyclic 6-alkylidene-penems as beta-lactamases inhibitors | |
TW200719903A (en) | Compositions for the treatment of neoplasms | |
ATE536178T1 (de) | Therapeutische anwendung von methionin zur behandlung oder prävention von mucositis | |
WO2022053993A3 (en) | Treatments for sars-cov-2 infection (covid-19) | |
TW200511999A (en) | Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and parathyroid hormone | |
TW200420290A (en) | Methods for the treatment, prevention and management of macular degeneration | |
EP1620061A4 (en) | ANTIVIRAL AGENTS FOR THE TREATMENT, CONTROL AND PREVENTION OF INFECTIONS BY CORONAVIRES | |
EA200801890A1 (ru) | Средство для лечения шума в ушах | |
IL174134A0 (en) | Use of a protein in the preparation of a medicament for treatment of fibrotic diseases | |
FI20010233A0 (fi) | Menetelmä sydämen vajaatoiminnan hoitoon | |
MXPA02007641A (es) | Uso de farmaceutico de la combinacion de fluconazol-tinidazol y su composicion para la administracion oral. | |
TW200509922A (en) | Methods of therapeutic treatment using amounts of retinoid components | |
WO2005000239A3 (en) | Lyase treatment for p. carinii | |
TW200519078A (en) | 2-alkylidene-19-nor-vitamin d derivatives for the treatment of a second hip fracture | |
NO20043774L (no) | The use of devazenide as analgesic agent | |
MY140242A (en) | BICYCLIC 6-ALKYLIDENE-PENEMS AS ß-LACTAMASES INHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |